“It is important to have a robust multidisciplinary approach to making decisions about the treatment of patients.”
Mr Hassan Malik (@nhsuhlg.bsky.social) shared the latest thinking on surgery and multidisciplinary care in cholangiocarcinoma. #AMMF2026 #Surgery #Cholangiocarcinoma
Mr Hassan Malik (@nhsuhlg.bsky.social) shared the latest thinking on surgery and multidisciplinary care in cholangiocarcinoma. #AMMF2026 #Surgery #Cholangiocarcinoma
May 13, 2026 at 3:10 PM
“It is important to have a robust multidisciplinary approach to making decisions about the treatment of patients.”
Mr Hassan Malik (@nhsuhlg.bsky.social) shared the latest thinking on surgery and multidisciplinary care in cholangiocarcinoma. #AMMF2026 #Surgery #Cholangiocarcinoma
Mr Hassan Malik (@nhsuhlg.bsky.social) shared the latest thinking on surgery and multidisciplinary care in cholangiocarcinoma. #AMMF2026 #Surgery #Cholangiocarcinoma
“Early access to therapy is critical and molecular testing is absolutely essential.”
Prof. John Bridgewater from UCL Cancer Institute, University College London explained how targeted therapies and immunotherapies are changing treatment for CCA.
#AMMF2026 #PrecisionMedicine #bileductcancer
Prof. John Bridgewater from UCL Cancer Institute, University College London explained how targeted therapies and immunotherapies are changing treatment for CCA.
#AMMF2026 #PrecisionMedicine #bileductcancer
May 13, 2026 at 2:12 PM
“Early access to therapy is critical and molecular testing is absolutely essential.”
Prof. John Bridgewater from UCL Cancer Institute, University College London explained how targeted therapies and immunotherapies are changing treatment for CCA.
#AMMF2026 #PrecisionMedicine #bileductcancer
Prof. John Bridgewater from UCL Cancer Institute, University College London explained how targeted therapies and immunotherapies are changing treatment for CCA.
#AMMF2026 #PrecisionMedicine #bileductcancer
“Reliable #biomarkers are crucial for early detection of #CCA.”
In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch
In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch
May 14, 2026 at 4:12 PM
“Reliable #biomarkers are crucial for early detection of #CCA.”
In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch
In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch
Prof. Primrose @unisouthampton.bsky.social shared lessons from Thailand’s experience in #CCA #screening and #surgery. A clinical visit showcased a high standard of surgery with excellent operative expertise, alongside a unique prevention and screening programme.
#AMMF2026 #GlobalHealth
#AMMF2026 #GlobalHealth
May 14, 2026 at 4:04 PM
Prof. Primrose @unisouthampton.bsky.social shared lessons from Thailand’s experience in #CCA #screening and #surgery. A clinical visit showcased a high standard of surgery with excellent operative expertise, alongside a unique prevention and screening programme.
#AMMF2026 #GlobalHealth
#AMMF2026 #GlobalHealth
#AMMF’s Founder and CEO Dr Helen Morement warmly welcomed today’s delegates to AMMF’s 2026 European Cholangiocarcinoma Conference.
“Patients are always at the heart of everything we do – today is about you.”
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
“Patients are always at the heart of everything we do – today is about you.”
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 13, 2026 at 1:38 PM
#AMMF’s Founder and CEO Dr Helen Morement warmly welcomed today’s delegates to AMMF’s 2026 European Cholangiocarcinoma Conference.
“Patients are always at the heart of everything we do – today is about you.”
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
“Patients are always at the heart of everything we do – today is about you.”
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
All #AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 14, 2026 at 7:00 AM
All #AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
“Pathology is hidden. You won’t ever meet anyone in the pathology department, but there are maybe 30-40 people involved.” Prof. Tim Kendall (@edinburgh-uni.bsky.social) highlighted the often unseen but critical role of pathology in the #cholangiocarcinoma patient journey. #AMMF2026 #Pathology
May 13, 2026 at 4:13 PM
“Pathology is hidden. You won’t ever meet anyone in the pathology department, but there are maybe 30-40 people involved.” Prof. Tim Kendall (@edinburgh-uni.bsky.social) highlighted the often unseen but critical role of pathology in the #cholangiocarcinoma patient journey. #AMMF2026 #Pathology
Dr Matt Evans (@uhsft.bsky.social) highlighted why molecular profiling is so important in #CCA care. “Early molecular testing not only helps patients get access to the right treatment, but it also helps healthcare professionals make an accurate diagnosis of CCA.”
#AMMF2026 #PrecisionMedicine
#AMMF2026 #PrecisionMedicine
May 14, 2026 at 9:51 AM
Dr Matt Evans (@uhsft.bsky.social) highlighted why molecular profiling is so important in #CCA care. “Early molecular testing not only helps patients get access to the right treatment, but it also helps healthcare professionals make an accurate diagnosis of CCA.”
#AMMF2026 #PrecisionMedicine
#AMMF2026 #PrecisionMedicine
Dr Meissner from Velindre Cancer Centre and Cardiff University explored the potential of liquid biopsy (ctDNA) in CCA diagnosis and monitoring.
“A liquid biopsy can capture the molecular profile of a patients’ tumour, complementary to tissue biopsy.”
#AMMF2026 #LiquidBiopsy #CCA
“A liquid biopsy can capture the molecular profile of a patients’ tumour, complementary to tissue biopsy.”
#AMMF2026 #LiquidBiopsy #CCA
May 13, 2026 at 2:53 PM
Dr Meissner from Velindre Cancer Centre and Cardiff University explored the potential of liquid biopsy (ctDNA) in CCA diagnosis and monitoring.
“A liquid biopsy can capture the molecular profile of a patients’ tumour, complementary to tissue biopsy.”
#AMMF2026 #LiquidBiopsy #CCA
“A liquid biopsy can capture the molecular profile of a patients’ tumour, complementary to tissue biopsy.”
#AMMF2026 #LiquidBiopsy #CCA
Take a look at some of the insights shared from world leading experts highlighted during #AMMF's 2026 European #Cholangiocarcinoma #Conference.
Raising awareness one 💜 at a time.
#bileductcancer #AMMF2026
Raising awareness one 💜 at a time.
#bileductcancer #AMMF2026
May 28, 2026 at 9:30 AM
Take a look at some of the insights shared from world leading experts highlighted during #AMMF's 2026 European #Cholangiocarcinoma #Conference.
Raising awareness one 💜 at a time.
#bileductcancer #AMMF2026
Raising awareness one 💜 at a time.
#bileductcancer #AMMF2026
The penultimate session at #AMMF’s 2026 European #Cholangiocarcinoma Conference is Fast Science, co-chaired by #CCA experts Professor Tim Kendall and Professor Kevin Gaston.
Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026
Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026
May 15, 2026 at 3:25 PM
The penultimate session at #AMMF’s 2026 European #Cholangiocarcinoma Conference is Fast Science, co-chaired by #CCA experts Professor Tim Kendall and Professor Kevin Gaston.
Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026
Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026
Interesting presentation on investigational breath-based biomarkers being evaluated for potential use in liver cancer detection. Dr Karagiannidis of Imperial College London outlined the underlying technology and ongoing validation work.
#AMMF2026 #Biomarkers #LiverCancer
#AMMF2026 #Biomarkers #LiverCancer
May 15, 2026 at 11:38 AM
Interesting presentation on investigational breath-based biomarkers being evaluated for potential use in liver cancer detection. Dr Karagiannidis of Imperial College London outlined the underlying technology and ongoing validation work.
#AMMF2026 #Biomarkers #LiverCancer
#AMMF2026 #Biomarkers #LiverCancer
Welcome to Day 3 the final day of #AMMF’s conference! Let's make it count!
You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 15, 2026 at 8:00 AM
Welcome to Day 3 the final day of #AMMF’s conference! Let's make it count!
You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
All AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees.
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 15, 2026 at 7:30 AM
All AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees.
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
As Day 2 of #AMMF’s 2026 European #Cholangiocarcinoma Conference comes to a close, we reflect on an insightful, information-packed day.
Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events...
#AMMF2026 #bileductcancer #CCA
Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events...
#AMMF2026 #bileductcancer #CCA
May 14, 2026 at 6:09 PM
As Day 2 of #AMMF’s 2026 European #Cholangiocarcinoma Conference comes to a close, we reflect on an insightful, information-packed day.
Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events...
#AMMF2026 #bileductcancer #CCA
Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events...
#AMMF2026 #bileductcancer #CCA
Spotlight on CCA in Wales - Ms Trish Duncan (University Hospital of Wales) highlighted variation in #care pathways and access across #Wales. #CCA does not currently have a national optimal pathway in Wales. “We need a greater awareness of CCA and improved reporting.”
#AMMF2026
#AMMF2026
May 14, 2026 at 3:52 PM
“Variation in adherence to best practice guidelines between centres persist.” Ms Jane McClements @belfasttrust.bsky.social presented results from the UK nationwide CAPBIL study evaluating care and outcomes in patients with intrahepatic CCA.
#AMMF2026 #BestPractice #CCA
#AMMF2026 #BestPractice #CCA
May 14, 2026 at 3:26 PM
“Variation in adherence to best practice guidelines between centres persist.” Ms Jane McClements @belfasttrust.bsky.social presented results from the UK nationwide CAPBIL study evaluating care and outcomes in patients with intrahepatic CCA.
#AMMF2026 #BestPractice #CCA
#AMMF2026 #BestPractice #CCA
"The complexity of #CCA surgery varies depending on tumour location with perihilar CCA remaining one of the most challenging subtypes to manage." Prof. Primrose (@unisouthampton.bsky.social) explored how surgical management for #CCA continues to evolve.
#AMMF2026 #Surgery #cholangiocarcinoma
#AMMF2026 #Surgery #cholangiocarcinoma
May 14, 2026 at 2:16 PM
"The complexity of #CCA surgery varies depending on tumour location with perihilar CCA remaining one of the most challenging subtypes to manage." Prof. Primrose (@unisouthampton.bsky.social) explored how surgical management for #CCA continues to evolve.
#AMMF2026 #Surgery #cholangiocarcinoma
#AMMF2026 #Surgery #cholangiocarcinoma